amphetamine has been researched along with tetraethylammonium in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X | 1 |
Bedwell, DW; Higgins, JW; Zamek-Gliszczynski, MJ | 1 |
Greenfield, SA; Webb, CP | 1 |
Jamieson, DD; Lander, J | 1 |
Bartolini, A; Capaccioli, S; Galeotti, N; Ghelardini, C; Pecori Vettori, A; Quattrone, A | 1 |
Chancy, CD; Ganapathy, V; Huang, W; Kekuda, R; Rajan, PD; Smith, SB | 1 |
Banchelli, G; Galeotti, N; Ghelardini, C; Pirisino, R; Raimondi, L | 2 |
DILLE, JM; WEST, TC | 1 |
9 other study(ies) available for amphetamine and tetraethylammonium
Article | Year |
---|---|
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium | 1999 |
Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Topics: Animals; Kidney; Liver; Male; Metformin; Mice; Mice, Knockout; Octamer Transcription Factor-1; Organic Cation Transport Proteins; Organic Cation Transporter 2; Tissue Distribution | 2012 |
Non-cholinergic effects of acetylcholinesterase in the substantia nigra: a possible role for an ATP-sensitive potassium channel.
Topics: Acetylcholinesterase; Adenosine Triphosphate; Amphetamine; Animals; Female; Glucose; Guinea Pigs; In Vitro Techniques; Male; Membrane Potentials; Mesencephalon; Neurons; Potassium Channels; Substantia Nigra; Tetraethylammonium; Tetraethylammonium Compounds; Tolbutamide; Tyrosine 3-Monooxygenase | 1992 |
Investigation of the mode of action of the anaesthetic agent, ketamine, in the heart of the bivalve mollusc Tapes watlingi.
Topics: Acetylcholine; Amphetamine; Animals; Dose-Response Relationship, Drug; Heart; Heart Rate; Ketamine; Methysergide; Metoclopramide; Mollusca; Phentolamine; Tetraethylammonium; Tetraethylammonium Compounds; Verapamil | 1984 |
Effect of K+ channel modulation on mouse feeding behaviour.
Topics: Amphetamine; Animals; Apamin; Cocaine; Feeding Behavior; Glucose; Guanidines; Injections, Intraventricular; Male; Mice; Minoxidil; Motor Activity; Oligonucleotides, Antisense; Pinacidil; Potassium Channel Blockers; Potassium Channels; Tetraethylammonium; Tetraethylammonium Compounds | 1997 |
Expression of the extraneuronal monoamine transporter in RPE and neural retina.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Biogenic Monoamines; Blotting, Northern; Carrier Proteins; Cells, Cultured; Eye; Female; Gene Expression; Humans; Hydrogen-Ion Concentration; In Situ Hybridization; Kinetics; Methamphetamine; Mice; Mice, Inbred ICR; Nicotine; Organic Cation Transport Proteins; Pigment Epithelium of Eye; Procainamide; Retina; RNA, Messenger; Steroids; Tetraethylammonium; Time Factors | 2000 |
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice.
Topics: Allyl Compounds; Amphetamine; Animals; Benzylamines; Clorgyline; Dopamine Agents; Drug Synergism; Feeding Behavior; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Propylamines; Pyridines; Selegiline; Serotonin Antagonists; Substrate Specificity; Tetraethylammonium | 2001 |
Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.
Topics: Allyl Compounds; Ammonium Chloride; Amphetamine; Animals; Anorexia; Behavior, Animal; Benzylamine Oxidase; Benzylamines; Charybdotoxin; DNA, Antisense; Dose-Response Relationship, Drug; Eating; Enzyme Inhibitors; Guanidines; Injections, Intraventricular; Kv1.1 Potassium Channel; Male; Methylamines; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Propylamines; Semicarbazides; Sulfonylurea Compounds; Tetraethylammonium | 2001 |
Reversal of the depressor effects of tetraethylammonium ion and of dihydroergotamine in the amphetamine tachyphylactic dog.
Topics: Amphetamine; Amphetamines; Animals; Blood Pressure; Cardiovascular Agents; Dihydroergotamine; Dogs; Ergot Alkaloids; Humans; Tetraethylammonium | 1953 |